Given the many effects of bile acids on the characteristics of the metabolic syndrome and type 2 diabetes, altering human metabolism via bile acids or bile acid receptor-mediated signalling is an appealing, yet complicated, approach. The gene discussed is NR1H4; the disease is type 2 diabetes mellitus.